These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32486166)

  • 21. Arsenic trioxide-induced p38 MAPK and Akt mediated MCL1 downregulation causes apoptosis of BCR-ABL1-positive leukemia cells.
    Huang CH; Lee YC; Chiou JT; Shi YJ; Wang LJ; Chang LS
    Toxicol Appl Pharmacol; 2020 Apr; 397():115013. PubMed ID: 32305283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells.
    Chiou JT; Chang LS
    Biochem Pharmacol; 2024 Jun; 224():116242. PubMed ID: 38679209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells.
    Chiou JT; Lee YC; Huang CH; Wang LJ; Shi YJ; Chang LS
    Biochem Pharmacol; 2021 Jun; 188():114544. PubMed ID: 33831396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A microRNA screen to identify modulators of sensitivity to BCL2 inhibitor ABT-263 (navitoclax).
    Lam LT; Lu X; Zhang H; Lesniewski R; Rosenberg S; Semizarov D
    Mol Cancer Ther; 2010 Nov; 9(11):2943-50. PubMed ID: 20829195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel tubulin polymerization inhibitor, MPT0B206, downregulates Bcr-Abl expression and induces apoptosis in imatinib-sensitive and imatinib-resistant CML cells.
    Chen CW; Lee YL; Liou JP; Liu YH; Liu CW; Chen TY; Huang HM
    Apoptosis; 2016 Sep; 21(9):1008-18. PubMed ID: 27344662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner.
    Kiprianova I; Remy J; Milosch N; Mohrenz IV; Seifert V; Aigner A; Kögel D
    Neoplasia; 2015 Jul; 17(7):564-73. PubMed ID: 26297434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTBP1 modulation of MCL1 expression regulates cellular apoptosis induced by antitubulin chemotherapeutics.
    Cui J; Placzek WJ
    Cell Death Differ; 2016 Oct; 23(10):1681-90. PubMed ID: 27367564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1.
    Li L; Pongtornpipat P; Tiutan T; Kendrick SL; Park S; Persky DO; Rimsza LM; Puvvada SD; Schatz JH
    Leukemia; 2015 Aug; 29(8):1702-12. PubMed ID: 25882699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Association Between p38 MAPK-Mediated TNF-α/TNFR2 up-Regulation and 2-(4-Aminophenyl)-7-Methoxybenzothiazole-Induced Apoptosis in Human Leukemia U937 Cells.
    Huang CH; Chen YJ; Chao TY; Liu WH; Changchien JJ; Hu WP; Chang LS
    J Cell Physiol; 2016 Jan; 231(1):130-41. PubMed ID: 26059963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1.
    Lee YC; Chen YJ; Huang CH; Chang LS
    Apoptosis; 2017 Mar; 22(3):406-420. PubMed ID: 27757735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines.
    Králová V; Hanušová V; Staňková P; Knoppová K; Čáňová K; Skálová L
    Anticancer Drugs; 2013 Oct; 24(9):911-9. PubMed ID: 23884106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells.
    Inoue C; Sobue S; Kawamoto Y; Nishizawa Y; Ichihara M; Abe A; Hayakawa F; Suzuki M; Nozawa Y; Murate T
    Biochem Biophys Res Commun; 2020 May; 525(4):1074-1080. PubMed ID: 32184020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of MCL1 function sensitizes the MDA-MB-231 breast cancer cells to rh-TRAIL by increasing DR4 levels.
    De Blasio A; Pratelli G; Drago-Ferrante R; Saliba C; Baldacchino S; Grech G; Tesoriere G; Scerri C; Vento R; Di Fiore R
    J Cell Physiol; 2019 Aug; 234(10):18432-18447. PubMed ID: 30912136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of ERK signaling evokes autocrine Fas-mediated death in arachidonic acid-treated human chronic myeloid leukemia K562 cells.
    Chen KC; Liu WH; Chang LS
    J Cell Physiol; 2010 Mar; 222(3):625-34. PubMed ID: 19927299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of apoptosis and autophagy by albendazole in human colon adenocarcinoma cells.
    Jung YY; Baek SH; Ha IJ; Ahn KS
    Biochimie; 2022 Jul; 198():155-166. PubMed ID: 35504402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative breast cancer, lung adenocarcinoma and glioblastoma multiforme.
    Lee A; Jin HO; Masudul Haque M; Kim HY; Jung H; Park JH; Kim I; Song JY; Yoon HK; Kim HK; Han J; Park IC; Kim KS; Park SG
    Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34913076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia.
    Qiao A; Wang K; Yuan Y; Guan Y; Ren X; Li L; Chen X; Li F; Chen AF; Zhou J; Yang JM; Cheng Y
    Oncotarget; 2016 Jul; 7(28):43390-43400. PubMed ID: 27270321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autophagy maintains ubiquitination-proteasomal degradation of Sirt3 to limit oxidative stress in K562 leukemia cells.
    Fang Y; Wang J; Xu L; Cao Y; Xu F; Yan L; Nie M; Yuan N; Zhang S; Zhao R; Wang H; Wu M; Zhang X; Wang J
    Oncotarget; 2016 Jun; 7(24):35692-35702. PubMed ID: 27232755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
    Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
    Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Benzo[B]Furans with Anti-Microtubule Activity Upregulate Expression of Apoptotic Genes and Arrest Leukemia Cells in G2/M Phase.
    Królewska-Golińska K; Cieślak MJ; Sobczak M; Dolot R; Radzikowska-Cieciura E; Napiórkowska M; Wybrańska I; Nawrot B
    Anticancer Agents Med Chem; 2019; 19(3):375-388. PubMed ID: 30465514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.